+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Alcohol Use Disorder Treatment Pipeline Analysis 2019 (H1)

  • ID: 4801768
  • Report
  • May 2019
  • Region: Global
  • 109 pages
  • Knowledge Sourcing Intelligence LLP

FEATURED COMPANIES

  • Addexx Therpeutics
  • Bioprojet SCR
  • Curemark LLC
  • Lohocla Research Corp
  • Montisera Ltd
  • Savant HWP, Inc.
Alcohol use disorder or alcohol dependence treatment pipeline analysis report covers more than 10 drugs currently in different phases of development. Alcohol dependence is a medical and behavioral disease which is characterized by alcohol-induced disturbances in brain structure, neurochemistry, and behavior. The major characteristics of alcohol dependence is an extreme urge to consume alcohol and difficulties in controlling the consumption of alcohol despite harmful consequences. Overcoming addiction is generally a long process that requires both personal will to give up alcohol along with various treatments or therapies.

The report provides alcohol use disorder treatment drugs by company, phases of development including products in early discovery stage and NDA filing, molecule type, route of administration and region. The report will help to evaluate the collaboration, in-licensing, and out-licensing opportunities, formulating business development strategies and tracking the activities of the key market players. Epidemiology, major drivers, restraints, and opportunities have been covered to provide an exhaustive picture of the market. The analysis presents in-depth information regarding the development, trends, and industry policies and regulations implemented to offer stakeholders a better understanding of the key factors affecting the overall market environment.

Various databases (for patents and Clinical Trials), studies and data published by industry associations, analyst reports, investor presentations, press releases and journals among others have been taken into consideration while conducting the secondary research.

Market intelligence is presented in the form of analysis, charts, and graphics to help the clients in gaining a faster and efficient understanding of the market.

Major industry players profiled as part of the report are Addexx Therapeutics, Silence Therapeutics Plc, Curemark LLC among others.

Scope:
  • By Company
  • By Phase
  • By Molecule Type
  • By Region
  • By Route of Administration
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Addexx Therpeutics
  • Bioprojet SCR
  • Curemark LLC
  • Lohocla Research Corp
  • Montisera Ltd
  • Savant HWP, Inc.
1. Introduction
1.1. Research Methodology
1.2. Research Scope
1.2.1. Analysis by Company
1.2.2. Analysis by Phase
1.2.3. By Molecule Type
1.2.4. By region

2. Disease Overview
2.1.1. Introduction
2.1.2. Classification
2.1.3. Symptoms
2.1.4. Causes
2.1.5. Diagnoses
2.1.6. Treatment
2.1.7. Epidemiology

3. Executive Summary

4. Market Dynamics
4.1. Drivers
4.2. Restraints
4.3. Opportunities

5. Pipeline Analysis/Outlook
5.1. Analysis by Company
5.2. Analysis by Phase
5.2.1. Phase of Development
5.2.1.1. Introduction
5.2.1.1.1. Drug Profiling
  • Drug Name
  • Generic Name
  • Synonyms
  • Company
  • Collaborator
  • Route of administration
  • Target
  • Mechanism of Action
  • Technology
  • Molecule type
  • CAS Number
  • Weight
  • Chemical Formula
  • IUPAC name
  • ATC code
5.2.1.1.2. Strategic Developments
5.2.1.1.3. Clinical trials
5.2.1.1.4. Clinical trial results
5.2.1.1.5. Patents
5.2.1.1.6. Technology
5.2.2. Comparative Analysis for Trials by Phase (Pie, Bar graph)
5.3. By Molecule type
5.4. Analysis by Region

6. Company profiling
6.1. Savant HWP, Inc.
6.1.1. Introduction
6.1.2. Financials
6.1.3. Products and Services
6.1.4. SWOT
6.1.5. Recent Development
6.2. Addexx Therapeutics
6.2.1. Introduction
6.2.2. Financials
6.2.3. Products and Services
6.2.4. SWOT
6.2.5. Recent Development
6.3. Opiant Pharmaceuticals, Inc
6.3.1. Introduction
6.3.2. Financials
6.3.3. Products and Services
6.3.4. SWOT
6.3.5. Recent Development
6.4. Omeros Corp
6.4.1. Introduction
6.4.2. Financials
6.4.3. Products and Services
6.4.4. SWOT
6.4.5. Recent Development
6.5. Adial Pharmaceuticals
6.5.1. Introduction
6.5.2. Financials
6.5.3. Products and Services
6.5.4. SWOT
6.5.5. Recent Development
6.6. Montisera Ltd
6.6.1. Introduction
6.6.2. Financials
6.6.3. Products and Services
6.6.4. SWOT
6.6.5. Recent Development
6.7. Ethypharm SA
6.7.1. Introduction
6.7.2. Financials
6.7.3. Products and Services
6.7.4. SWOT
6.7.5. Recent Development
6.8. Medicinova
6.8.1. Introduction
6.8.2. Financials
6.8.3. Products and Services
6.8.4. SWOT
6.8.5. Recent Development
6.9. Amygdala Neurosciences, Inc.
6.9.1. Introduction
6.9.2. Financials
6.9.3. Products and Services
6.9.4. SWOT
6.9.5. Recent Development
6.10. Curemark LLC
6.10.1. Introduction
6.10.2. Financials
6.10.3. Products and Services
6.10.4. SWOT
6.10.5. Recent Development
6.11. Kinnov Therapeutics
6.11.1. Introduction
6.11.2. Financials
6.11.3. Products and Services
6.11.4. SWOT
6.11.5. Recent Development
6.12. BioCorRx, Inc
6.12.1. Introduction
6.12.2. Financials
6.12.3. Products and Services
6.12.4. SWOT
6.12.5. Recent Development
6.13. Corcept Therapeutics Inc
6.13.1. Introduction
6.13.2. Financials
6.13.3. Products and Services
6.13.4. SWOT
6.13.5. Recent Development
6.14. Bionex Pharmaceuticals LLC
6.14.1. Introduction
6.14.2. Financials
6.14.3. Products and Services
6.14.4. SWOT
6.14.5. Recent Development
6.15. Bioprojet SCR
6.15.1. Introduction
6.15.2. Financials
6.15.3. Products and Services
6.15.4. SWOT
6.15.5. Recent Development
6.16. Chronos Therapeutics Ltd
6.16.1. Introduction
6.16.2. Financials
6.16.3. Products and Services
6.16.4. SWOT
6.16.5. Recent Development
6.17. Lohocla Research Corp
6.17.1. Introduction
6.17.2. Financials
6.17.3. Products and Services
6.17.4. SWOT
6.17.5. Recent Developments
6.18. Lohocla Research Corp
6.18.1. Introduction
6.18.2. Financials
6.18.3. Products and Services
6.18.4. SWOT
6.18.5. Recent Developments
6.19. Silence Therapeutics Plc
6.19.1. Introduction
6.19.2. Financials
6.19.3. Products and Services
6.19.4. SWOT
6.19.5. Recent Developments
6.20. Syntropharma Limited
6.20.1. Introduction
6.20.2. Financials
6.20.3. Products and Services
6.20.4. SWOT
6.20.5. Recent Developments
6.21. Laboratorio Farmaceutico Ct S.r.l.
6.21.1. Introduction
6.21.2. Financials
6.21.3. Products and Services
6.21.4. SWOT
6.21.5. Recent Development
6.22. Pop Test Oncology LLC
6.22.1. Introduction
6.22.2. Financials
6.22.3. Products and Services
6.22.4. SWOT
6.22.5. Recent Development
Note: Product cover images may vary from those shown
  • Savant HWP, Inc.
  • Addexx Therpeutics
  • Opiant Pharmaceuticals, Inc
  • Omeros Corp
  • Adial Pharmaceuticals
  • Montisera Ltd
  • Ethypharm SA
  • Medicinova
  • Amygdala Neurosciences, Inc.
  • Curemark LLC
  • Kinnov Therapeutics
  • BioCorRx, Inc
  • Corcept Therapeutics Inc
  • Bionex Pharmaceuticals LLC
  • Bioprojet SCR
  • Chronos Therapeutics Ltd
  • Lohocla Research Corp
  • Lohocla Research Corp
  • Silence Therapeutics Plc
  • Syntropharma Limited
  • Laboratorio Farmaceutico Ct S.r.l.
  • Pop Test Oncology LLC
Note: Product cover images may vary from those shown
Adroll
adroll